Carregando...

Genetically Engineered Islets and Alternative Sources of Insulin-Producing Cells for Treating Autoimmune Diabetes: Quo Vadis?

Islet transplantation is a promising therapy for patients with type 1 diabetes that can provide moment-to-moment metabolic control of glucose and allow them to achieve insulin independence. However, two major problems need to be overcome: (1) detrimental immune responses, including inflammation indu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Chou, Feng-Cheng, Huang, Shing-Hwa, Sytwu, Huey-Kang
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368364/
https://ncbi.nlm.nih.gov/pubmed/22690214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/296485
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!